Design of a Green Monopropellant Propulsion System for the Lunar Flashlight CubeSat Mission

Lunar Flashlight is a 6U CubeSat mission from NASA\u27s Jet Propulsion Laboratory that will search for water-ice deposits near the lunar south pole. Lunar Flashlight aims to add to the flight experience of deep-space CubeSats by demonstrating an orbit insertion using a green monopropellant propulsion system designed uniquely for this mission. Developed by NASA Marshall Spaceflight Center (MSFC) and Georgia Tech\u27s Space Systems Design Laboratory (SSDL), the Lunar Flashlight Propulsion System (LFPS) delivers over 2500N-s of total impulse for the orbit insertion and necessary attitude maneuvers. The custom propulsion system fits within a 2.5U volume and has a total wet mass of less than six kilograms. It will be fueled byAF-M315E, which is a green monopropellant developed by the Air Force Research Laboratory (AFRL) as a safer alternative to hydrazine. Additive manufacturing is utilized to fabricate several components of its primary structure. Upon completion, Lunar Flashlight may become the first CubeSat to achieve orbit around a celestial body besides Earth. The LFPS aims to be a pathfinder device for CubeSat missions by demonstrating how monopropellant systems, green monopropellant fuel, and additive manufacturing can be utilized to expand the reach of small satellite space exploration

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Introduction: The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures. Methods: In a prospective, UK-wide, multicentre MRI follow-up study (C-MORE), adults (aged ≥18 years) discharged from hospital following COVID-19 who were included in Tier 2 of the Post-hospitalisation COVID-19 study (PHOSP-COVID) and contemporary controls with no evidence of previous COVID-19 (SARS-CoV-2 nucleocapsid antibody negative) underwent multiorgan MRI (lungs, heart, brain, liver, and kidneys) with quantitative and qualitative assessment of images and clinical adjudication when relevant. Individuals with end-stage renal failure or contraindications to MRI were excluded. Participants also underwent detailed recording of symptoms, and physiological and biochemical tests. The primary outcome was the excess burden of multiorgan abnormalities (two or more organs) relative to controls, with further adjustments for potential confounders. The C-MORE study is ongoing and is registered with ClinicalTrials.gov, NCT04510025. Findings: Of 2710 participants in Tier 2 of PHOSP-COVID, 531 were recruited across 13 UK-wide C-MORE sites. After exclusions, 259 C-MORE patients (mean age 57 years [SD 12]; 158 [61%] male and 101 [39%] female) who were discharged from hospital with PCR-confirmed or clinically diagnosed COVID-19 between March 1, 2020, and Nov 1, 2021, and 52 non-COVID-19 controls from the community (mean age 49 years [SD 14]; 30 [58%] male and 22 [42%] female) were included in the analysis. Patients were assessed at a median of 5·0 months (IQR 4·2–6·3) after hospital discharge. Compared with non-COVID-19 controls, patients were older, living with more obesity, and had more comorbidities. Multiorgan abnormalities on MRI were more frequent in patients than in controls (157 [61%] of 259 vs 14 [27%] of 52; p<0·0001) and independently associated with COVID-19 status (odds ratio [OR] 2·9 [95% CI 1·5–5·8]; padjusted=0·0023) after adjusting for relevant confounders. Compared with controls, patients were more likely to have MRI evidence of lung abnormalities (p=0·0001; parenchymal abnormalities), brain abnormalities (p<0·0001; more white matter hyperintensities and regional brain volume reduction), and kidney abnormalities (p=0·014; lower medullary T1 and loss of corticomedullary differentiation), whereas cardiac and liver MRI abnormalities were similar between patients and controls. Patients with multiorgan abnormalities were older (difference in mean age 7 years [95% CI 4–10]; mean age of 59·8 years [SD 11·7] with multiorgan abnormalities vs mean age of 52·8 years [11·9] without multiorgan abnormalities; p<0·0001), more likely to have three or more comorbidities (OR 2·47 [1·32–4·82]; padjusted=0·0059), and more likely to have a more severe acute infection (acute CRP >5mg/L, OR 3·55 [1·23–11·88]; padjusted=0·025) than those without multiorgan abnormalities. Presence of lung MRI abnormalities was associated with a two-fold higher risk of chest tightness, and multiorgan MRI abnormalities were associated with severe and very severe persistent physical and mental health impairment (PHOSP-COVID symptom clusters) after hospitalisation. Interpretation: After hospitalisation for COVID-19, people are at risk of multiorgan abnormalities in the medium term. Our findings emphasise the need for proactive multidisciplinary care pathways, with the potential for imaging to guide surveillance frequency and therapeutic stratification

The technocratic labor thesis revisited

In the 1970s Australian New Left theorists used the Technocratic Labor thesis to criticize the ALP. This held that middle-class university educated people were taking over the ALP and moving it to the right. Thirty years later there appears to be much substance to their argument. The ALP has increasingly been led by middle-class people and has moved to the right. It has also narrowed the recruiting base for its national parliamentarians, most of who are now groomed within the party and its affiliates rather than being drawn from the wider community. Nonetheless, the political utility of the argument may be questioned since most of the Australian workforce is now in the services sector and many are also middle class and university educated

Intrinsic Properties of Stoichiometric LaFePo

DC and ac magnetization, resistivity, specific-heat, and neutron-diffraction data reveal that stoichiometric LaFePO is metallic and non-superconducting above T=0.35K, with γ=12.5 mJ mol K2. Neutron-diffraction data at room temperature and T=10K are well described by the stoichiometric, tetragonal ZrCuSiAs structure, and show no signs of structural distortions or long-range magnetic ordering to an estimated detectability limit of 0.07 μB /Fe. We propose a model based on the shape of the iron-pnictide tetrahedron that explains the differences between LaFePO and LaFeAsO, the parent compound of the recently discovered high-Tc oxyarsenides, which, in contrast, shows both structural and spin-density wave transitions

Tuning the Charge Density Wave and Superconductivity in Cuₓ TaS₂

We report the characterization of layered 2H -type Cux TaS2 for 0≤x≤0.12. The charge density wave (CDW), at 70 K for TaS2, is destabilized with Cu doping. The sub-1 K superconducting transition in undoped 2H -TaS2 jumps quickly to 2.5 K at low x, increases to 4.5 K at the optimal composition Cu0.04 TaS2, and then decreases at higher x. The electronic contribution to the specific heat, first increasing and then decreasing as a function of Cu content, is 12 mJ mol-1 K-2 at Cu0.04 TaS2. Electron-diffraction studies show that the CDW remains present at the optimal superconducting composition but with both a changed q vector and decreased coherence length. We present an electronic phase diagram for the system